|
CA2213638C
(en)
|
1995-02-24 |
2004-05-04 |
Nanosystems L.L.C. |
Aerosols containing nanoparticle dispersions
|
|
US20010031244A1
(en)
*
|
1997-06-13 |
2001-10-18 |
Chiesi Farmaceutici S.P.A. |
Pharmaceutical aerosol composition
|
|
SE9704186D0
(sv)
*
|
1997-11-14 |
1997-11-14 |
Astra Ab |
New composition of matter
|
|
US7521068B2
(en)
*
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
|
DZ2947A1
(fr)
|
1998-11-25 |
2004-03-15 |
Chiesi Farma Spa |
Inhalateur à compteur de dose sous pression.
|
|
US6315985B1
(en)
*
|
1999-06-18 |
2001-11-13 |
3M Innovative Properties Company |
C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
|
|
US6576224B1
(en)
*
|
1999-07-06 |
2003-06-10 |
Sinuspharma, Inc. |
Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
|
|
US20020061281A1
(en)
*
|
1999-07-06 |
2002-05-23 |
Osbakken Robert S. |
Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
|
|
IT1313553B1
(it)
*
|
1999-07-23 |
2002-09-09 |
Chiesi Farma Spa |
Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
|
|
AU7026800A
(en)
*
|
1999-09-11 |
2001-04-17 |
Glaxo Group Limited |
Pharmaceutical formulation of fluticasone propionate
|
|
WO2001047491A1
(en)
*
|
1999-12-23 |
2001-07-05 |
Coifman Robert E |
Methods and formulations for the efficient delivery of water-insoluble drugs by nebulizer
|
|
ES2238334T3
(es)
*
|
1999-12-24 |
2005-09-01 |
Glaxo Group Limited |
Formulacion farmaceutica en aerosol de salmeterol y propionato de fluticasona.
|
|
IT1317720B1
(it)
*
|
2000-01-07 |
2003-07-15 |
Chiesi Farma Spa |
Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
|
|
IT1317846B1
(it)
|
2000-02-22 |
2003-07-15 |
Chiesi Farma Spa |
Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
|
|
IT1318514B1
(it)
*
|
2000-05-12 |
2003-08-27 |
Chiesi Farma Spa |
Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
|
|
JP5392880B2
(ja)
*
|
2000-05-22 |
2014-01-22 |
キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ |
加圧式定量吸入器のための安定な製薬学的溶液製剤
|
|
US6623765B1
(en)
*
|
2000-08-01 |
2003-09-23 |
University Of Florida, Research Foundation, Incorporated |
Microemulsion and micelle systems for solubilizing drugs
|
|
US6787532B2
(en)
*
|
2000-08-05 |
2004-09-07 |
Smithkline Beecham Corporation |
Formulation containing anti-inflammatory androstane derivatives
|
|
US20030072717A1
(en)
|
2001-02-23 |
2003-04-17 |
Vapotronics, Inc. |
Inhalation device having an optimized air flow path
|
|
US20030055026A1
(en)
*
|
2001-04-17 |
2003-03-20 |
Dey L.P. |
Formoterol/steroid bronchodilating compositions and methods of use thereof
|
|
US6667344B2
(en)
|
2001-04-17 |
2003-12-23 |
Dey, L.P. |
Bronchodilating compositions and methods
|
|
DE60213228T2
(de)
*
|
2001-05-21 |
2007-06-21 |
Injet Digital Aerosols Ltd., North Ryde |
Zusammensetzungen für die freisetzung von protein auf dem pulmonalen weg
|
|
US7090830B2
(en)
|
2001-05-24 |
2006-08-15 |
Alexza Pharmaceuticals, Inc. |
Drug condensation aerosols and kits
|
|
US7498019B2
(en)
|
2001-05-24 |
2009-03-03 |
Alexza Pharmaceuticals, Inc. |
Delivery of compounds for the treatment of headache through an inhalation route
|
|
US7585493B2
(en)
|
2001-05-24 |
2009-09-08 |
Alexza Pharmaceuticals, Inc. |
Thin-film drug delivery article and method of use
|
|
US7766013B2
(en)
*
|
2001-06-05 |
2010-08-03 |
Alexza Pharmaceuticals, Inc. |
Aerosol generating method and device
|
|
US7645442B2
(en)
|
2001-05-24 |
2010-01-12 |
Alexza Pharmaceuticals, Inc. |
Rapid-heating drug delivery article and method of use
|
|
CA2641760A1
(en)
*
|
2001-05-24 |
2002-11-28 |
Alexza Pharmaceuticals, Inc. |
Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route
|
|
US20070122353A1
(en)
|
2001-05-24 |
2007-05-31 |
Hale Ron L |
Drug condensation aerosols and kits
|
|
US7458374B2
(en)
|
2002-05-13 |
2008-12-02 |
Alexza Pharmaceuticals, Inc. |
Method and apparatus for vaporizing a compound
|
|
CA2446904A1
(en)
*
|
2001-05-24 |
2003-04-03 |
Alexza Pharmaceuticals, Inc. |
Delivery of drug esters through an inhalation route
|
|
US6759029B2
(en)
*
|
2001-05-24 |
2004-07-06 |
Alexza Molecular Delivery Corporation |
Delivery of rizatriptan and zolmitriptan through an inhalation route
|
|
ES2222294T3
(es)
*
|
2001-07-02 |
2005-02-01 |
Chiesi Farmaceutici S.P.A. |
Formulacion optimizada de tobramicina para administracion en forma de aerosol.
|
|
WO2003041693A1
(en)
*
|
2001-11-09 |
2003-05-22 |
Alexza Molecular Delivery Corporation |
Delivery of diazepam through an inhalation route
|
|
CA2460343A1
(en)
|
2001-11-21 |
2003-07-17 |
Alexza Molecular Delivery Corporation |
Delivery of caffeine through an inhalation route
|
|
BR0214679A
(pt)
*
|
2001-12-03 |
2004-12-14 |
Novacea Inc |
Composições farmacêuticas compreendendo compostos a base de vitamina d ativa
|
|
US20030178022A1
(en)
*
|
2001-12-21 |
2003-09-25 |
Chiesi Farmaceutici S.P.A. |
Pressurized metered dose inhaler (PMDI) actuators and medicinal aerosol solution formulation products comprising therse actuators
|
|
US20030129242A1
(en)
*
|
2002-01-04 |
2003-07-10 |
Bosch H. William |
Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer
|
|
DE60302454T2
(de)
*
|
2002-04-19 |
2006-08-17 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Beta-agonisten-verbindungen mit stickoxid-donatoren-gruppen und reaktionsfähige sauerstoffspezies-fängergruppen und ihre verwendung bei der behandlung von atemwegsstörungen
|
|
EP1503744A1
(en)
|
2002-05-13 |
2005-02-09 |
Alexza Molecular Delivery Corporation |
Delivery of drug amines through an inhalation route
|
|
GB2404349B
(en)
*
|
2002-05-21 |
2006-06-07 |
Unversity Of Massachusetts |
Low pressure impact separator for separation, classification and collection of ultrafine particles
|
|
JP2005531570A
(ja)
*
|
2002-05-23 |
2005-10-20 |
ユーエムディー， インコーポレイテッド |
貫粘膜薬物送達及び凍結保護のための組成物及び方法
|
|
GB2389530B
(en)
|
2002-06-14 |
2007-01-10 |
Cipla Ltd |
Pharmaceutical compositions
|
|
WO2004004640A2
(en)
*
|
2002-07-05 |
2004-01-15 |
Tetragrammaton Inc. |
Methods, compositions and kits for treating damage to excitable tissue
|
|
US20040023935A1
(en)
*
|
2002-08-02 |
2004-02-05 |
Dey, L.P. |
Inhalation compositions, methods of use thereof, and process for preparation of same
|
|
US20040045546A1
(en)
|
2002-09-05 |
2004-03-11 |
Peirce Management, Llc |
Pharmaceutical delivery system for oral inhalation through nebulization consisting of inert substrate impregnated with substance (S) to be solubilized or suspended prior to use
|
|
US20060247216A1
(en)
*
|
2002-10-25 |
2006-11-02 |
Haj-Yehia Abdullah I |
Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
|
|
US7550133B2
(en)
*
|
2002-11-26 |
2009-06-23 |
Alexza Pharmaceuticals, Inc. |
Respiratory drug condensation aerosols and methods of making and using them
|
|
WO2004047844A1
(en)
*
|
2002-11-26 |
2004-06-10 |
Alexza Pharmaceuticals, Inc. |
Use of loxapine and amoxapine for the manufacture of a medicament for the treatment of pain
|
|
NZ540208A
(en)
*
|
2002-11-26 |
2007-09-28 |
Alexza Pharmaceuticals Inc |
Treatment of headache with antipsychotics delivered by inhalation
|
|
US20040105818A1
(en)
|
2002-11-26 |
2004-06-03 |
Alexza Molecular Delivery Corporation |
Diuretic aerosols and methods of making and using them
|
|
US7913688B2
(en)
|
2002-11-27 |
2011-03-29 |
Alexza Pharmaceuticals, Inc. |
Inhalation device for producing a drug aerosol
|
|
US20050026877A1
(en)
*
|
2002-12-03 |
2005-02-03 |
Novacea, Inc. |
Pharmaceutical compositions comprising active vitamin D compounds
|
|
US20040109826A1
(en)
*
|
2002-12-06 |
2004-06-10 |
Dey, L.P. |
Stabilized albuterol compositions and method of preparation thereof
|
|
ES2312844T3
(es)
*
|
2002-12-12 |
2009-03-01 |
Nycomed Gmbh |
Medicamento de combinacion de r, r-formoterol y ciclesonida.
|
|
ITMI20022674A1
(it)
*
|
2002-12-18 |
2004-06-19 |
Chiesi Farma Spa |
Procedimento per la preparazione di formulazioni sterili a base di principi attivi farmaceutici cristallini micronizzati da somministrare come sospensioni acquose per inalazione.
|
|
US20040208833A1
(en)
*
|
2003-02-04 |
2004-10-21 |
Elan Pharma International Ltd. |
Novel fluticasone formulations
|
|
DE602004015755D1
(de)
*
|
2003-03-31 |
2008-09-25 |
Alza Corp |
Nicht wässrige einphasige visköse vehikel und formulierungen die diese vehikel verwenden
|
|
US8912174B2
(en)
*
|
2003-04-16 |
2014-12-16 |
Mylan Pharmaceuticals Inc. |
Formulations and methods for treating rhinosinusitis
|
|
US9808471B2
(en)
*
|
2003-04-16 |
2017-11-07 |
Mylan Specialty Lp |
Nasal pharmaceutical formulations and methods of using the same
|
|
US7811606B2
(en)
*
|
2003-04-16 |
2010-10-12 |
Dey, L.P. |
Nasal pharmaceutical formulations and methods of using the same
|
|
EP1625333A1
(en)
|
2003-05-21 |
2006-02-15 |
Alexza Pharmaceuticals, Inc. |
Self-contained heating unit and drug-supply unit employing same
|
|
US20050020546A1
(en)
*
|
2003-06-11 |
2005-01-27 |
Novacea, Inc. |
Pharmaceutical compositions comprising active vitamin D compounds
|
|
TWI359675B
(en)
|
2003-07-10 |
2012-03-11 |
Dey L P |
Bronchodilating β-agonist compositions
|
|
AU2004271744B2
(en)
*
|
2003-09-16 |
2010-07-29 |
Covis Pharma B.V. |
Use of ciclesonide for the treatment of respiratory diseases
|
|
DE10347994A1
(de)
*
|
2003-10-15 |
2005-06-16 |
Pari GmbH Spezialisten für effektive Inhalation |
Wässrige Aerosol-Zubereitung
|
|
ITMI20032054A1
(it)
*
|
2003-10-22 |
2005-04-23 |
Monteres S R L |
Processo per la preparazione di sospensioni farmaceutiche da inalare.
|
|
PE20050941A1
(es)
*
|
2003-12-16 |
2005-11-08 |
Nycomed Gmbh |
Suspensiones acuosas de ciclesonida para nebulizacion
|
|
CA2550811C
(en)
*
|
2003-12-24 |
2012-05-01 |
Jane Hirsh |
Temperature-stable formulations, and methods of development thereof
|
|
US20070020196A1
(en)
*
|
2003-12-31 |
2007-01-25 |
Pipkin James D |
Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension
|
|
RU2006127432A
(ru)
|
2003-12-31 |
2008-02-10 |
Сайдекс, Инк. (Us) |
Ингаляционная композиция, содержащая сульфоалкиловый эфир циклодекстрина и кортикостероид, полученная из единичной дозы суспензии
|
|
US20070020298A1
(en)
*
|
2003-12-31 |
2007-01-25 |
Pipkin James D |
Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid
|
|
US20070020299A1
(en)
*
|
2003-12-31 |
2007-01-25 |
Pipkin James D |
Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
|
|
US20050175679A1
(en)
*
|
2004-02-10 |
2005-08-11 |
Michael Moshman |
Controlled release formulations
|
|
EP1595531A1
(en)
|
2004-05-13 |
2005-11-16 |
CHIESI FARMACEUTICI S.p.A. |
Stable pharmaceutical solution formulations for pressurized metered dose inhalers
|
|
US7892483B2
(en)
*
|
2004-03-12 |
2011-02-22 |
Cipla Limited |
Sterilization process
|
|
ATE446581T1
(de)
*
|
2004-03-12 |
2009-11-15 |
Trinity College Dublin |
Magnetoresistives medium
|
|
EP1740188A1
(en)
*
|
2004-04-20 |
2007-01-10 |
Altana Pharma AG |
Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
|
|
GB0410995D0
(en)
*
|
2004-05-17 |
2004-06-23 |
Norton Healthcare Ltd |
Heat sterilization of glucocorticosteroids
|
|
US7540286B2
(en)
|
2004-06-03 |
2009-06-02 |
Alexza Pharmaceuticals, Inc. |
Multiple dose condensation aerosol devices and methods of forming condensation aerosols
|
|
EP2246086A3
(en)
|
2004-08-12 |
2012-11-21 |
Alexza Pharmaceuticals, Inc. |
Aerosol drug delivery device incorporating percussively activated heating unit
|
|
US20060045850A1
(en)
*
|
2004-08-30 |
2006-03-02 |
Qpharma, Llc |
Nasal delivery of cyclodextrin complexes of anti-inflammatory steroids
|
|
US20060073173A1
(en)
*
|
2004-10-04 |
2006-04-06 |
Maria Banach |
Large-scale manufacturing process for the production of pharmaceutical compositions
|
|
DK2377557T3
(en)
*
|
2004-11-24 |
2017-02-06 |
Meda Pharmaceuticals Inc |
Compositions comprising azelastine and methods for its use
|
|
US20070020330A1
(en)
*
|
2004-11-24 |
2007-01-25 |
Medpointe Healthcare Inc. |
Compositions comprising azelastine and methods of use thereof
|
|
US8758816B2
(en)
*
|
2004-11-24 |
2014-06-24 |
Meda Pharmaceuticals Inc. |
Compositions comprising azelastine and methods of use thereof
|
|
US8277780B2
(en)
*
|
2005-05-27 |
2012-10-02 |
Taro Pharmaceutical North America, Inc. |
Stable liquid desoximethasone compositions with reduced oxidized impurity
|
|
US20070027105A1
(en)
|
2005-07-26 |
2007-02-01 |
Alza Corporation |
Peroxide removal from drug delivery vehicle
|
|
US8497258B2
(en)
|
2005-11-12 |
2013-07-30 |
The Regents Of The University Of California |
Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
|
|
US20070160542A1
(en)
*
|
2005-12-20 |
2007-07-12 |
Verus Pharmaceuticals, Inc. |
Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile
|
|
US20070178049A1
(en)
*
|
2005-12-20 |
2007-08-02 |
Verus Pharmaceuticals, Inc. |
Systems and methods for the delivery of corticosteroids having an enhanced pharmacokinetic profile
|
|
US20070249572A1
(en)
*
|
2005-12-20 |
2007-10-25 |
Verus Pharmaceuticals, Inc. |
Systems and methods for the delivery of corticosteroids
|
|
US20070185066A1
(en)
*
|
2005-12-20 |
2007-08-09 |
Verus Pharmaceuticals, Inc. |
Systems and methods for the delivery of corticosteroids
|
|
US20070197486A1
(en)
*
|
2005-12-20 |
2007-08-23 |
Verus Pharmaceuticals, Inc. |
Methods and systems for the delivery of corticosteroids
|
|
US20070178051A1
(en)
*
|
2006-01-27 |
2007-08-02 |
Elan Pharma International, Ltd. |
Sterilized nanoparticulate glucocorticosteroid formulations
|
|
JP2009526858A
(ja)
*
|
2006-02-15 |
2009-07-23 |
ティカ レーケメデル アーベー |
コルチコステロイド溶液を製造する方法
|
|
CA2642229C
(en)
|
2006-02-24 |
2015-05-12 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
|
EP2121088B1
(en)
|
2007-03-09 |
2016-07-13 |
Alexza Pharmaceuticals, Inc. |
Heating unit for use in a drug delivery device
|
|
FR2916974B1
(fr)
*
|
2007-06-11 |
2010-11-26 |
Univ Angers |
Procede de preparation de nanoparticules lipidiques
|
|
US12370352B2
(en)
|
2007-06-28 |
2025-07-29 |
Cydex Pharmaceuticals, Inc. |
Nasal and ophthalmic delivery of aqueous corticosteroid solutions
|
|
ES2667945T3
(es)
|
2007-10-08 |
2018-05-16 |
Aurinia Pharmaceuticals Inc. |
Composiciones oftálmicas que comprenden inhibidores de calcineurina o Inhibidores de mTOR
|
|
US20090143343A1
(en)
|
2007-11-13 |
2009-06-04 |
Meritage Pharma, Inc. |
Compositions for the treatment of inflammation of the gastrointestinal tract
|
|
EP2214679B1
(en)
|
2007-11-13 |
2019-03-27 |
Meritage Pharma, Inc. |
Corticosteroid compositions
|
|
JP6002385B2
(ja)
|
2008-09-12 |
2016-10-05 |
クリティカル ファーマシューティカルズ リミテッドＣｒｉｔｉｃａｌ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｉｍｉｔｅｄ |
医薬組成物、医薬組成物における吸収促進剤の使用方法、及び医薬組成物の製造方法
|
|
PL2565193T3
(pl)
|
2009-01-23 |
2014-07-31 |
Rigel Pharmaceuticals Inc |
Kompozycje i sposoby hamowania szlaku JAK
|
|
JP2013518097A
(ja)
|
2010-01-26 |
2013-05-20 |
イッサム リサーチ ディヴェロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム エルティーディー |
肺高血圧を予防および治療するための組成物および方法
|
|
ES2391721T3
(es)
*
|
2010-03-01 |
2012-11-29 |
Laboratorios Salvat, S.A. |
Disoluciones acuosas transparentes de acetónido de fluocinolona para el tratamiento de la infamación de oído
|
|
CN102448496B
(zh)
*
|
2011-06-22 |
2015-04-15 |
江苏德达医药科技有限公司 |
含碘和类固醇的药物组合物及其用于治疗鼻炎疾病的用途
|
|
CA2865504A1
(en)
|
2012-03-23 |
2013-09-26 |
Oxigene, Inc. |
Compositions and methods for inhibition of cathepsins
|
|
AR096459A1
(es)
*
|
2013-06-03 |
2015-12-30 |
Tolmar Inc |
Composiciones de corticosteroides y método de fabricación
|
|
US10111956B2
(en)
|
2013-06-03 |
2018-10-30 |
Tolmar, Inc. |
Corticosteroid compositions
|
|
EP3094355A1
(en)
|
2014-01-17 |
2016-11-23 |
Nephron Pharmaceuticals Corporation |
Budesonide cyclodextrin formulation
|
|
US20190224275A1
(en)
|
2017-05-12 |
2019-07-25 |
Aurinia Pharmaceuticals Inc. |
Protocol for treatment of lupus nephritis
|
|
EP3746138B1
(en)
|
2018-02-02 |
2025-12-10 |
Alexza Pharmaceuticals, Inc. |
Electrical condensation aerosol device
|
|
US20220000880A1
(en)
|
2018-11-01 |
2022-01-06 |
Rigel Pharmaceuticals, Inc. |
Method and composition embodiments for treating acute myeloid leukemia
|
|
US20200377518A1
(en)
|
2019-05-29 |
2020-12-03 |
Rigel Pharmaceuticals, Inc. |
Method of preventing and treating thrombosis
|
|
BR112022001418A2
(pt)
|
2019-08-08 |
2022-06-07 |
Rigel Pharmaceuticals Inc |
Compostos e método para tratar a síndrome de liberação de citocinas
|
|
ES2970382T3
(es)
|
2019-08-14 |
2024-05-28 |
Rigel Pharmaceuticals Inc |
Método para bloquear o mejorar el síndrome de liberación de citocinas
|
|
JP2023515918A
(ja)
|
2020-01-13 |
2023-04-17 |
デュレクト コーポレーション |
不純物が低減された徐放性薬物送達システム及び関連の方法
|
|
CN114642677A
(zh)
*
|
2020-12-21 |
2022-06-21 |
上海凯屹医药科技有限公司 |
一种稳定的含有苦丁皂苷类化合物的液体药物组合物
|
|
CA3203561A1
(en)
|
2021-01-12 |
2022-07-21 |
Adrian Neil Verity |
Sustained release drug delivery systems and related methods
|
|
JP2025513716A
(ja)
|
2022-03-23 |
2025-04-30 |
ライジェル・ファーマシューティカルズ・インコーポレイテッド |
Ｉｒａｋ阻害剤としてのピリミド－２－イル－ピラゾール化合物
|